Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients.

Clinical and pathological variables were compared with mortality.

The 5-year survival rate of stage 0-I-II was 89.5% and stage III-IV was 18.5%.

In the bivariate analysis, variables associated with lower survival were: aged over 42 years, histologic subtypes, Breslow thickness ≥ 0.8mm, ulceration, vascular invasion, metastatic melanoma, positive sentinel node, more than 1 positive node, LDH > 200 IU/L, distant metastasis, and stage III-IV.